Save your place

Sign in to WhoBought

Please try again later.

Sarepta Therapeutics, Inc. (SRPT) institutional ownership

Latest close $15.88 Jul 23, 2026
Market cap$1.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
326
reported SRPT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
153 buyers · 173 sellers

Sarepta Therapeutics, Inc. (SRPT) price and institutional activity

Dates

Q1 2026

$0 bought by 153 investors
Ra Capital Management, L.P.Two Sigma Investments, LP +151 more
$0 sold by 173 investors
Two Sigma Advisers, LPAQR Capital Management LLC +171 more
Bought Sold Totals per quarter; hover a bar for the names.

Sarepta Therapeutics, Inc. (SRPT) institutional activity · 326

Investor Type Est. change Change Δ Own Date
Ra Capital Management, L.P. · New
Change +3.9M Date Q1 2026
Ra Capital Management, L.P. New· Q1 2026 +3.9M Q1 2026
Two Sigma Investments, LP · Added
Change +2.2M Δ Own +88.1% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +2.2M +88.1% Q1 2026
First Trust Advisors LP · Added
Change +2.1M Date Q1 2026
First Trust Advisors LP Added· Q1 2026 +2.1M Q1 2026
Two Sigma Advisers, LP · Exited
Change −2.1M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −2.1M −100.0% Q1 2026
AQR Capital Management LLC · Reduced
Change −1.4M Date Q1 2026
AQR Capital Management LLC Reduced· Q1 2026 −1.4M Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −1.1M Δ Own −69.2% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −1.1M −69.2% Q1 2026
Canada Pension Plan Investment Board · Added
Change +896K Date Q1 2026
Canada Pension Plan Investment Board Added· Q1 2026 +896K Q1 2026
Morgan Stanley · Added
Change +684K Date Q1 2026
Morgan Stanley Added· Q1 2026 +684K Q1 2026
Legal & General · Added
Change +602K Date Q1 2026
Legal & General Added· Q1 2026 +602K Q1 2026
Marshall Wace, LLP · Added
Change +582K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +582K Q1 2026
Hotchkis & Wiley Capital Management LLC · New
Change +560K Date Q1 2026
Hotchkis & Wiley Capital Management LLC New· Q1 2026 +560K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +533K +449.3% Q1 2026
Goldman Sachs Group Inc · Added
Change +515K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +515K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +506K +43.6% Q1 2026
Federated Hermes, Inc. · Added
Change +473K Date Q1 2026
Federated Hermes, Inc. Added· Q1 2026 +473K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 326

Famous investor activity in Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics, Inc. (SRPT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Boor Kathryn Jean · Director Grant (A) 17K
Owned 25K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Boor Kathryn Jean Director Grant (A) 17K 25K Jun 4, 2026 Jun 5, 2026
Mayo Stephen · Director Grant (A) 17K
Owned 19K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Mayo Stephen Director Grant (A) 17K 19K Jun 4, 2026 Jun 5, 2026
Wigzell Hans Lennart Rudolf · Director Grant (A) 17K
Owned 42K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Wigzell Hans Lennart Rudolf Director Grant (A) 17K 42K Jun 4, 2026 Jun 5, 2026
Behrens M. Kathleen · Director Grant (A) 17K
Owned 214K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Behrens M. Kathleen Director Grant (A) 17K 214K Jun 4, 2026 Jun 5, 2026
Connelly Deirdre P. · Director Grant (A) 17K
Owned 22K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Connelly Deirdre P. Director Grant (A) 17K 22K Jun 4, 2026 Jun 5, 2026
Nicaise Claude · Director Grant (A) 17K
Owned 48K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Nicaise Claude Director Grant (A) 17K 48K Jun 4, 2026 Jun 5, 2026
Chambers Michael Andrew · Director Grant (A) 17K
Owned 28K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Chambers Michael Andrew Director Grant (A) 17K 28K Jun 4, 2026 Jun 5, 2026
Barry Richard · Director Grant (A) 17K
Owned 3.0M Trade date Jun 4, 2026 Filed date Jun 5, 2026
Barry Richard Director Grant (A) 17K 3.0M Jun 4, 2026 Jun 5, 2026
Mayo Stephen · Director Sell −$123K
Price $17.02 Qty −7K Owned 2K Trade date Mar 12, 2026 Filed date Mar 13, 2026
Mayo Stephen Director Sell $17.02 −7K −$123K 2K Mar 12, 2026 Mar 13, 2026
Estepan Ian Michael · Officer Tax withholding or exercise payment (F) -$19K
Price $17.03 Qty -1K Owned 202K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Estepan Ian Michael Officer Tax withholding or exercise payment (F) $17.03 -1K -$19K 202K Mar 11, 2026 Mar 13, 2026
Wong Ryan Ho-Yan · Officer Tax withholding or exercise payment (F) -$4K
Price $17.03 Qty -256 Owned 135K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Wong Ryan Ho-Yan Officer Tax withholding or exercise payment (F) $17.03 -256 -$4K 135K Mar 11, 2026 Mar 13, 2026
Rodino-Klapac Louise · Officer Tax withholding or exercise payment (F) -$16K
Price $17.03 Qty -948 Owned 225K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Rodino-Klapac Louise Officer Tax withholding or exercise payment (F) $17.03 -948 -$16K 225K Mar 11, 2026 Mar 13, 2026
Rothfuss Cristin · Officer Tax withholding or exercise payment (F) -$17K
Price $17.03 Qty -974 Owned 138K Trade date Mar 11, 2026 Filed date Mar 13, 2026
Rothfuss Cristin Officer Tax withholding or exercise payment (F) $17.03 -974 -$17K 138K Mar 11, 2026 Mar 13, 2026
Wong Ryan Ho-Yan · Officer 2 operations -$5K
Price $16.95 Qty -275 Owned 135K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Wong Ryan Ho-Yan Officer 2 operations $16.95 -275 -$5K 135K Mar 9, 2026 Mar 11, 2026
Rothfuss Cristin · Officer 2 operations -$14K
Price $16.95 Qty -830 Owned 139K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Rothfuss Cristin Officer 2 operations $16.95 -830 -$14K 139K Mar 9, 2026 Mar 11, 2026
15 of 45
15 of 45 Sign in to continue to older insider transactions.

Sarepta Therapeutics, Inc. (SRPT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 10.1M
% of shares outstanding 10.7% Filing date Jun 7, 2024
BlackRock Inc. 10.1M 10.7% Jun 7, 2024
Vanguard Group Inc 8.8M
% of shares outstanding 9.4% Filing date Feb 13, 2024
Vanguard Group Inc 8.8M 9.4% Feb 13, 2024
Capital International Investors 6.4M
% of shares outstanding 6.7% Filing date Nov 13, 2024
Capital International Investors 6.4M 6.7% Nov 13, 2024
Vanguard Portfolio Management 6.8M
% of shares outstanding 6.4% Filing date Apr 29, 2026
Vanguard Portfolio Management 6.8M 6.4% Apr 29, 2026
Vanguard Capital Management 5.4M
% of shares outstanding 5.1% Filing date Apr 30, 2026
Vanguard Capital Management 5.4M 5.1% Apr 30, 2026
Capital Research Global Investors 3.8M
% of shares outstanding 4.8% Filing date Aug 10, 2021
Capital Research Global Investors 3.8M 4.8% Aug 10, 2021
Janus Henderson Group PLC 4.4M
% of shares outstanding 4.6% Filing date Nov 14, 2024
Janus Henderson Group PLC 4.4M 4.6% Nov 14, 2024
FMR LLC 3.0M
% of shares outstanding 3.4% Filing date Feb 9, 2022
FMR LLC 3.0M 3.4% Feb 9, 2022
8 of 9

Sarepta Therapeutics, Inc. (SRPT) ownership FAQ

Who owns SRPT?

326 reporting institutions disclosed SRPT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.